562 results on '"Childhood cancer survivor"'
Search Results
202. Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30 years of life: A French multicentre cohort study.
- Author
-
Demoor-Goldschmidt, C., Supiot, S., Oberlin, O., Helfre, S., Vigneron, C., Brillaud-Meflah, V., Bernier, V., Laprie, A., Ducassou, A., Claude, L., Mahé, M.A., and De Vathaire, F.
- Subjects
- *
BREAST cancer diagnosis , *RADIOTHERAPY , *BREAST cancer risk factors , *CHILDHOOD cancer , *BREAST cancer research ,RISK factors - Abstract
Purpose Irradiation (>3 Gy) to the breast or axillae before 30 years of age increases the risk of secondary breast cancer (SBC). The purpose of this article is to describe the clinical characteristics of SBC and the way of diagnosis in young women (before the age of national screening) in France who had received previous radiotherapy for a childhood or a young adulthood cancer. Patients and methods This retrospective, multicentre study reviewed the medical records of women with SBC before the age of the national screening who had received irradiation (≥3 Gy) on part or all of the breast before 30 years of age, for any type of tumour except BC. Results A total of 121 SBC were detected in 104 women with previous radiotherapy. Twenty percent of SBC were detected during regular breast screening and 16% of the women had a regular radiological follow-up. Conclusion Our results points out that the main proportion of childhood cancer survivors did not benefit from the recommended breast cancer screening. This result is comparable to other previously published studies in other countries. A national screening programme is necessary and should take into account the patient’s age, family history, personal medical history and previous radiotherapy to reduce the number of SBC diagnosed at an advanced stage. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
203. Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma.
- Author
-
Lie, Hanne, Mellblom, Anneli, Brekke, Mette, Finset, Arnstein, Fosså, Sophie, Kiserud, Cecilie, Ruud, Ellen, Loge, Jon, Lie, Hanne C, Mellblom, Anneli V, Fosså, Sophie D, Kiserud, Cecilie E, and Loge, Jon H
- Subjects
- *
EXPERIENCE , *CHILDHOOD cancer , *MEDICARE , *LYMPHOMAS , *ONCOLOGISTS , *LYMPHOMA treatment , *FOCUS groups , *PATIENT aftercare , *PSYCHOLOGY - Abstract
Purpose: Given childhood cancer survivors' risk of treatment-induced late effects, long-term follow-up care is recommended. We explored experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood malignant lymphoma in Norway.Methods: We conducted five focus group interviews with 34 survivors (19 females; 21 Hodgkin/13 non-Hodgkin lymphoma survivors; mean age 39 years; mean time from diagnosis 26 years). Data was analyzed using principles of thematic analysis.Results: Two main themes were identified: (1) the survivors' experiences with late effects-related care and (2) their preferences for long-term follow-up care. Most of the survivors were dissatisfied with their late effects-related care due to perceptions of poor coordination of healthcare needs in a fragmented system, combined with a perceived lack of knowledge of late effects among themselves and general practitioners (GPs). All survivors valued long-term follow-up care. Oncologists were the preferred care providers, but GPs were considered acceptable providers if they had sufficient knowledge of late effects and routine examinations, short waiting times, and improved GP-oncologist collaboration.Conclusions: Our results suggest that a shared care model of long-term follow-up care involving specialists, GPs, and the survivors themselves is likely to fulfill several of the currently unmet needs among adult survivors of childhood cancers. Improved patient education about late effects and follow-up care would aid self-management. The survivors' concerns regarding lack of sufficient knowledge of late effects among GPs suggest a need for improving access to, and dissemination of, information of late effects. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
204. A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme.
- Author
-
Demoor-Goldschmidt, Charlotte, Drui, Delphine, Doutriaux, Isabelle, Michel, Gérard, Auquier, Pascal, Dumas, Agnès, Berger, Claire, Bernier, Valérie, Bohrer, Sandrine, Bondiau, Pierre-Yves, Filhon, Bruno, Fresneau, Brice, Freycon, Claire, Stefan, Dinu, Helfre, Sylvie, Jackson, Angela, Kerr, Christine, Laprie, Anne, Leseur, Julie, and Mahé, Marc-André
- Subjects
- *
CANCER patients , *CANCER in adolescence , *CHILDHOOD cancer , *BREAST cancer diagnosis , *THYROID cancer , *BREAST tumor diagnosis , *THYROID gland tumors , *SECONDARY primary cancer , *BREAST , *MEDICAL screening , *THYROID gland , *EARLY detection of cancer , *DIAGNOSIS - Abstract
Background: Survival of childhood, adolescent and young adult (CAYA) cancers has increased with progress in the management of the treatments and has reached more than 80% at 5 years. Nevertheless, these survivors are at great risk of second cancers and non-malignant co-morbidities in later life. DeNaCaPST is a non-interventional study whose aim is to organize a national screening for thyroid cancer and breast cancer in survivors of CAYA cancers. It will study the compliance with international recommendations, with the aim, regarding a breast screening programme, of offering for every woman living in France, at equal risk, an equal screening.Method: DeNaCaPST trial is coordinated by the INSERM 1018 unit in cooperation with the LEA (French Childhood Cancer Survivor Study for Leukaemia) study's coordinators, the long term follow up committee and the paediatric radiation committee of the SFCE (French Society of Childhood Cancers). A total of 35 centres spread across metropolitan France and la Reunion will participate. FCCSS (French Childhood Cancer Survivor Study), LEA and central registry will be interrogated to identify eligible patients. To participate, centers agreed to perform a complete "long-term follow-up consultations" according to good clinical practice and the guidelines of the SFCE (French Society of Children Cancers).Discussion: As survival has greatly improved in childhood cancers, detection of therapy-related malignancies has become a priority even if new radiation techniques will lead to better protection for organs at risk. International guidelines have been put in place because of the evidence for increased lifetime risk of breast and thyroid cancer. DeNaCaPST is based on these international recommendations but it is important to recognize that they are based on expert consensus opinion and are supported by neither nonrandomized observational studies nor prospective randomized trials in this specific population. Over-diagnosis is a phenomenon inherent in any screening program and therefore such programs must be evaluated. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
205. Childbirth and fertility preservation in childhood and adolescent cancer patients: a second national survey of Japanese pediatric endocrinologists.
- Author
-
Yoko Miyoshi, Tohru Yorifuji, Reiko Horikawa, Ikuko Takahashi, Keisuke Nagasaki, Hiroyuki Ishiguro, Ikuma Fujiwara, Junko Ito, Mari Oba, Hiroyuki Fujisaki, Masashi Kato, Chikako Shimizu, Tomoyasu Kato, Kimikazu Matsumoto, Haruhiko Sago, Tetsuya Takimoto, Hiroshi Okada, Nao Suzuki, Susumu Yokoya, and Tsutomu Ogata
- Subjects
- *
CHILDBIRTH , *FERTILITY preservation , *CANCER patients , *CHILDHOOD cancer , *PEDIATRIC endocrinology - Abstract
Although existing guidelines recommend long-term follow-up of childhood cancer survivors (CCSs), their fertility has not been fully investigated in Japan. To address this issue, we organized a working panel consisting of medical specialists in foundation hospitals. We conducted questionnaire surveys targeting pediatric endocrinologists regarding reproduction in pediatric and adolescent cancer patients in collaboration with the CCS committee of the Japanese Society for Pediatric Endocrinology (JSPE). The first questionnaire was sent to 178 directors or councilors of the JSPE, and the second was sent to those who had provided answers on their experience with childbirth or fertility preservation. A total of 151 responses (84.8%) were obtained in the first survey. In the second survey, the response rate was 100% (39 respondents). There were 27 answers describing experiences with childbirth (16 from partners of male CCSs, 22 from female CCSs). A few cases of premature birth and low birth weight were reported. There were 25 answers describing experiences with fertility preservation; 21 were from male and 17 from female CCSs. It was mainly physicians who recommended fertility preservation. This nationwide questionnaire survey revealed that a limited number of Japanese pediatric endocrinologists had experience with childbirth and fertility preservation in CCSs. A further long-term follow-up study of their fertility is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
206. Effect of Population Socioeconomic and Health System Factors on Medical Care of Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.
- Author
-
Caplin, Deirdre A., Smith, Ken R., Ness, Kirsten K., Hanson, Heidi A., Smith, Stephanie M., Nathan, Paul C., Hudson, Melissa M., Leisenring, Wendy M., Robison, Leslie L., and Oeffinger, Kevin C.
- Subjects
- *
CARDIOMYOPATHIES , *MAMMOGRAMS , *CANCER patients , *CONFIDENCE intervals , *DATABASES , *ECHOCARDIOGRAPHY , *HEALTH , *HEALTH status indicators , *MEDICAL care , *MEDICAL screening , *PHYSICIANS , *SURGEONS , *MULTIPLE regression analysis , *SOCIOECONOMIC factors , *ODDS ratio , *CHILDREN , *CARDIOVASCULAR diseases risk factors - Abstract
The article focuses on the socioeconomic and health system factors of the population on childhood cancer medical care and screening including enrollment in the Childhood Cancer Survivor Study (CCSS) and individual-level factors from U.S. Area Health Resource File was reported.
- Published
- 2017
- Full Text
- View/download PDF
207. Diabetes in childhood cancer survivors: emerging concepts in pathophysiology and future directions.
- Author
-
Bhandari R, Armenian SH, McCormack S, Natarajan R, and Mostoufi-Moab S
- Abstract
With advancements in cancer treatment and supportive care, there is a growing population of childhood cancer survivors who experience a substantial burden of comorbidities related to having received cancer treatment at a young age. Despite an overall reduction in the incidence of most chronic health conditions in childhood cancer survivors over the past several decades, the cumulative incidence of certain late effects, in particular diabetes mellitus (DM), has increased. The implications are significant, because DM is a key risk factor for cardiovascular disease, a leading cause of premature death in childhood cancer survivors. The underlying pathophysiology of DM in cancer survivors is multifactorial. DM develops at younger ages in survivors compared to controls, which may reflect an "accelerated aging" phenotype in these individuals. The treatment-related exposures (i.e., chemotherapy, radiation) that increase risk for DM in childhood cancer survivors may be more than additive with established DM risk factors (e.g., older age, obesity, race, and ethnicity). Emerging research also points to parallels in cellular processes implicated in aging- and cancer treatment-related DM. Still, there remains marked inter-individual variability regarding risk of DM that is not explained by demographic and therapeutic risk factors alone. Recent studies have highlighted the role of germline genetic risk factors and epigenetic modifications that are associated with risk of DM in both the general and oncology populations. This review summarizes our current understanding of recognized risk factors for DM in childhood cancer survivors to help inform targeted approaches for disease screening, prevention, and treatment. Furthermore, it highlights the existing scientific gaps in understanding the relative contributions of individual therapeutic exposures and the mechanisms by which they exert their effects that uniquely predispose this population to DM following cancer treatment., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor NS declared a past co-authorship with the author SA., (Copyright © 2023 Bhandari, Armenian, McCormack, Natarajan and Mostoufi-Moab.)
- Published
- 2023
- Full Text
- View/download PDF
208. Healthcare utilization and cost barriers among U.S. childhood cancer survivors.
- Author
-
Nghiem VT, Alanaeme CJ, Mennemeyer ST, and Wong FL
- Subjects
- Humans, Child, Delivery of Health Care, Patient Acceptance of Health Care, Cancer Survivors, Influenza Vaccines, Neoplasms therapy, Neoplasms epidemiology
- Abstract
Background: To evaluate healthcare utilization and cost barrier patterns among childhood cancer survivors (CCS) compared with noncancer controls., Procedure: Using the 2014-2019 Behavioral Risk Factor Surveillance System, we identified CCS < 50 years and matched controls. We used chi-squared tests to compare characteristics between the two groups. Logistic regression analyses were used to assess the likelihood of having a checkup, receiving influenza vaccine, and experiencing healthcare cost barriers (being unable to see the doctor due to cost) during the past 12 months. Conditional models accounted for the matching., Results: We included 231 CCS and 692 controls. CCS had lower household income (p < 0.001), lower educational attainment (p = 0.021), more chronic health conditions (p < 0.001), and a higher proportion of being current smokers (p = 0.005) than controls. Both groups had similar rates of having a checkup and influenza vaccine; however, a quarter of CCS experienced healthcare cost barriers compared with 13.9% in controls (p = 0.001; regression findings: adjusted odds ratio (aOR) = 1.72, 95% confidence interval (CI): 1.11-2.65). Compared with the youngest CCS group (18-24 years), CCS ages 25-29 years were five times more likely to experience healthcare cost barriers (aOR = 4.79; 95% CI, 1.39-16.54). Among CCS, current smokers were less likely to have a checkup (aOR = 0.46; 95% CI, 0.23-0.94). Uninsured CCS were less likely to have a checkup (aOR = 0.33; 95% CI, 0.14-0.75) and ∼8 times more likely to experience healthcare cost barriers (aOR = 8.28; 95% CI, 3.45-19.88)., Conclusion: CCS being 25-29 years, uninsured, or current smokers encounter inferior outcomes in healthcare utilization and cost barriers. We suggest emphasis on programs on care transition and smoking cessation for CCS., (© 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
209. Integrating Psychosocial Research and Practice in a Pediatric Hospital
- Author
-
Kazak, Anne E., Meadows, Anna T., Roberts, Michael C., editor, Peterson, Lizette, editor, and Drotar, Dennis, editor
- Published
- 2000
- Full Text
- View/download PDF
210. Risk of Second Malignancies Following Treatment for Genitourinary Tumors
- Author
-
Formenti, S. C., Corso, F. A., Baert, A. L., editor, Heuck, F. H. W., editor, Youker, J. E., editor, Brady, L. W., editor, Heilmann, H.-P., editor, Petrovich, Zbigniew, editor, Baert, Luc, editor, and Brady, Luther W., editor
- Published
- 1999
- Full Text
- View/download PDF
211. Metabolic syndrome detection with biomarkers in childhood cancer survivors
- Author
-
F.U.S. Mattace-Raso, R. de Jonge, S.J.C.M.M. Neggers, V G Pluimakers, M. P. M. de Maat, Martin Huisman, Patric J.D. Delhanty, C W N Looman, M.M. van den Heuvel-Eibrink, M. van Waas, Pediatrics, Public Health, Hematology, Internal Medicine, Clinical chemistry, and Amsterdam Gastroenterology Endocrinology Metabolism
- Subjects
Oncology ,medicine.medical_specialty ,childhood cancer survivor ,Waist ,Apolipoprotein B ,principal component analysis ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,lcsh:Diseases of the endocrine glands. Clinical endocrinology ,metabolic syndrome ,chemistry.chemical_compound ,neuroblastoma ,Endocrinology ,SDG 3 - Good Health and Well-being ,Internal medicine ,Internal Medicine ,medicine ,lcsh:RC648-665 ,Adiponectin ,biology ,business.industry ,Research ,medicine.disease ,Nephrectomy ,chemistry ,Cohort ,nephroblastoma ,biology.protein ,Biomarker (medicine) ,Uric acid ,biomarker ,Metabolic syndrome ,business - Abstract
Purpose: Augmented survival of childhood nephroblastoma and neuroblastoma has increased long-term side effects such as metabolic syndrome (MetS). Risk stratification is difficult after abdominal radiation because waist circumference underestimates adiposity. We aimed to develop a strategy for determining MetS in irradiated survivors using an integrated biomarker profile and vascular ultrasonography. Methods: The NCEP-ATPIII MetS-components, 14 additional serum biomarkers and 9 vascular measurements were assessed in a single-centre cohort of childhood nephroblastoma (n = 67) and neuroblastoma (n = 36) survivors and controls (n = 61). Multivariable regression models were used to study treatment effects. Principal component analysis (PCA) was used to study all biomarkers in a combined analysis, to identify patterns and correlations. Results: After 27.5 years of follow-up, MetS occurred more often in survivors (14%) than controls (3%). Abdominal radiotherapy and nephrectomy, to a lesser extent, were associated with MetS and separate components and with several biomarker abnormalities. PCA of biomarkers revealed a pattern on PC1 from favourable lipid markers (HDL-cholesterol, adiponectin) towards unfavourable markers (triglycerides, LDL-cholesterol, apoB, uric acid). Abdominal radiotherapy was associated with the unfavourable biomarker profile (β = 1.45, P = 0.001). Vascular measurements were not of added diagnostic value. Conclusions: Long-term childhood nephro- and neuroblastoma survivors frequently develop MetS. Additional assessment of biomarkers identified in PCA – adiponectin, LDL, apoB, and uric acid – may be used especially in abdominally irradiated survivors, to classify MetS as alternative for waist circumference. Vascular ultrasonography was not of added value.
- Published
- 2020
- Full Text
- View/download PDF
212. A nationwide questionnaire survey targeting Japanese pediatric endocrinologists regarding transitional care in childhood, adolescent, and young adult cancer survivors
- Author
-
Hiroyuki Ishiguro, Noriyuki Takubo, Keisuke Nagasaki, Keiichi Ozono, Junko Ito, Koji Muroya, Masanobu Kawai, Yoko Miyoshi, Reiko Horikawa, Satoshi Okada, Tohru Yorifuji, Susumu Yokoya, Junko Kanno, and Chikako Shimizu
- Subjects
Infertility ,medicine.medical_specialty ,childhood cancer survivor ,Pediatric endocrinology ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,medicine ,Transitional care ,030212 general & internal medicine ,Young adult ,Response rate (survey) ,Pregnancy ,business.industry ,adolescent and young adult ,Cancer ,Questionnaire ,transition ,medicine.disease ,questionnaire survey ,Family medicine ,Pediatrics, Perinatology and Child Health ,Original Article ,business ,pediatric endocrinologist - Abstract
Existing guidelines recommend long-term follow-up of childhood cancer survivors (CCS). However, in Japan, transitional care for CCS has not been established. To ascertain the current status in Japan, and to cultivate a better understanding, a questionnaire survey was conducted on transitional care in CCS, and adolescent and young adult (AYA) cancer survivors. Questionnaires were distributed to 183 councilors (137 institutions) of the Japanese Society for Pediatric Endocrinology. A total of 131 responses, representative of 174 councilors, were obtained. The response rate was 95%. Among the respondents, 91% had experience in medical care for cancer patients, while 63% had experience in transitional care; however, the number of patients referred to adult clinics was small. Further, 89% acknowledged the availability of adult endocrinologists who were willing to accept these patients; although their numbers were insufficient. Pediatric endocrinologists highlighted difficulties in medical examinations concerning infertility, obesity, pregnancy/delivery, and gonadal dysfunction, in that order. Staff and time shortages were listed as some of the challenges faced by medical staff, while multisystem morbidity was listed for patients. This nationwide questionnaire survey revealed that Japanese pediatric endocrinologists require cooperation between related departments and collaborative infrastructure to develop transitional care for cancer survivors.
- Published
- 2020
213. Automated Global Longitudinal Strain Assessment in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia
- Author
-
Rafael Gonzalez-Manzanares, Juan Castillo, Jose Molina, Martin Ruiz-Ortiz, Dolores Mesa, Soledad Ojeda, Manuel Anguita, and Manuel Pan
- Subjects
childhood cancer survivor ,Cancer Research ,cardio-oncology ,Oncology ,cardiotoxicity ,global longitudinal strain ,echocardiography ,cardiovascular system ,cardiovascular diseases ,humanities - Abstract
There is limited evidence that supports the use of the global longitudinal strain (GLS) in long-term cardiac monitoring of childhood acute lymphoblastic leukemia survivors (CLSs). Our aim was to assess the utility of automated GLS to detect left ventricular systolic dysfunction (LVSD) in long-term CLSs. Asymptomatic and subclinical LVSD were defined as LVEF < 50% and GLS < 18.5%, respectively. Echocardiographic measurements and biomarkers were compared with a control group. Inverse probability weighting was used to reduce confounding. Regression models were used to identify factors associated with LVEF and GLS in the survivors. Ninety survivors with a median follow-up of 18 (11–26) years were included. The prevalence of LVSD was higher using GLS than with LVEF (26.6% vs. 12.2%). The measurements were both reduced as compared with the controls (p < 0.001). There were no differences in diastolic parameters and NT-ProBNP. Survivors were more likely to have Hs-cTnI levels above the detection limit (40% vs. 17.2%, p = 0.006). The dose of anthracycline was associated with LVEF but not with GLS in the survivors. Biomarkers were not associated with GLS or LVEF. In conclusion, LVSD detection using automated GLS was higher than with LVEF in long-term CLSs. Its incorporation into clinical routine practice may improve the surveillance of these patients.
- Published
- 2022
214. The PanCareFollowUp Care Intervention:A European harmonised approach to person-centred guideline-based survivorship care after childhood, adolescent and young adult cancer
- Author
-
Rebecca J. van Kalsbeek, Renée L. Mulder, Riccardo Haupt, Monica Muraca, Lars Hjorth, Cecilia Follin, Tomas Kepak, Katerina Kepakova, Anne Uyttebroeck, Marlies Mangelschots, Jeanette Falck Winther, Jacqueline J. Loonen, Gisela Michel, Edit Bardi, Line Elmerdahl Frederiksen, Jaap den Hartogh, Luzius Mader, Katharina Roser, Carina Schneider, Morven C. Brown, Melanie Brunhofer, Irene Göttgens, Rosella P.M.G. Hermens, Anita Kienesberger, Joke C. Korevaar, Roderick Skinner, Helena J.H. van der Pal, Leontine C.M. Kremer, Paediatric Oncology, CCA - Cancer Treatment and Quality of Life, and ARD - Amsterdam Reproduction and Development
- Subjects
Quality of life ,Cancer Research ,Adolescent ,Long-term follow-up care ,Person-centred care ,610 Medicine & health ,Survivorship ,humanities ,Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] ,Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] ,Cancer survivorship care ,Young Adult ,Oncology ,Cancer Survivors ,360 Social problems & social services ,Neoplasms ,Quality of Life ,Humans ,Survivors ,Shared decision-making ,Childhood cancer survivor - Abstract
Contains fulltext : 248815.pdf (Publisher’s version ) (Open Access) BACKGROUND: Long-term follow-up (LTFU) care, although endorsed, is not available for the majority of adult survivors of childhood, adolescence and young adult (CAYA) cancer. Barriers to implementation include lack of time, knowledge, personnel and funding. Sustainable solutions are urgently needed to address the needs of CAYA cancer survivors to improve the quality of life and reduce the burden of late effects on survivors, health care systems and society. The European Union-funded PanCareFollowUp project, initiated by the Pan-European Network for Care of Survivors after Childhood and Adolescent Cancer, was established to facilitate the implementation of person-centred survivorship care across Europe. PATIENTS AND METHODS: The PanCareFollowUp Care Intervention was co-developed with survivors as part of the PanCareFollowUp project. It is a person-centred approach to survivorship care, supported by guidelines and with flexibility to adapt to local health care settings. The Care Intervention consists of three steps: (1) previsit completion of a Survivor Questionnaire (by the survivor) and Treatment Summary (by the health care provider [HCP]), (2) a clinic visit including shared decision-making, and (3) a follow-up call to finalise the individualised Survivorship Care Plan. RESULTS: We developed the key components of the PanCareFollowUp Care Intervention: a PanCareFollowUp Survivor Questionnaire, Treatment Summary template, Survivorship Care Plan template, and educational materials for HCPs and survivors. Wide implementation of the PanCareFollowUp Care Intervention will be supported with a freely distributed Replication Manual on completion of the PanCareFollowUp project. CONCLUSIONS: The PanCareFollowUp Care Intervention will support the implementation of person-centred, guideline-based LTFU care in different health care settings across Europe to improve survivors' health and well-being.
- Published
- 2022
- Full Text
- View/download PDF
215. Exploring Posttraumatic Stress Symptoms and Posttraumatic Growth among Children Living beyond Cancer and Their Parents Using an Actor–Partner Interdependence Model
- Author
-
Amanda Wurz, Michaela Patton, Erin L. Merz, Sharon H. J. Hou, Sara Cho, and Fiona Schulte
- Subjects
Cancer Research ,childhood cancer survivor ,Oncology ,pediatric cancer ,survivorship ,psychological health ,APIM ,parent-child ,relationships ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
There is a growing focus on describing both negative and positive outcomes in the wake of childhood cancer. The purpose of this study was to describe and explore the relationships between posttraumatic stress symptoms (PTSS) and posttraumatic growth (PTG) among children living beyond cancer and one of their parents. As part of a larger online survey, 113 children (Mage at time of study = 15.82 (SD = 4.81); Mage at diagnosis = 5.86 (SD = 4.66)) and one of their parents completed questionnaires assessing PTSS and PTG. Descriptive statistics were used to describe the sample and levels of PTSS and PTG. Data were z-transformed and analyzed using bivariate correlations and t-tests. An actor–partner interdependence model (APIM) was used to test whether children’s and their parents’ PTSS was associated with their own PTG (actor effect) and the others’ PTG (partner effect). PTSS was low and PTG was moderate in this sample relative to scale ranges. There were no significant differences between the children’s and their parents’ PTSS (p = 0.535) or PTG (p = 0.534). Results from the APIM showed no significant actor effects (p = 0.185). A significant overall partner effect (p = 0.020) emerged. Lower PTSS for children was associated with greater PTG for their parents (b = −0.29, p = 0.018), but parent’s PTSS was not associated with children’s PTG (p = 0.434). This sample reported similar levels of PTSS and PTG to that which has been reported in the literature. Children and their parents’ scores on PTSS and PTG measures were not significantly different from one another. Children’s PTSS was negatively associated with their parents PTG, illuminating the ways in which PTSS and PTG may be related in the context of childhood cancer. Exploring family-based strategies to reduce PTSS and enhance PTG may be warranted, though further studies are required.
- Published
- 2022
- Full Text
- View/download PDF
216. Late effects of cancer therapy
- Author
-
Morgan, Elaine R., Haugen, Maureen, Rosen, Steven T., editor, Walterhouse, David O., editor, and Cohn, Susan L., editor
- Published
- 1997
- Full Text
- View/download PDF
217. Overview
- Author
-
Schwartz, Cindy L., Hobbie, Wendy L., Constine, Louis S., Ruccione, Kathleen S., Schwartz, Cindy L., editor, Hobbie, Wendy L., editor, Constine, Louis S., editor, and Ruccione, Kathleen S., editor
- Published
- 2005
- Full Text
- View/download PDF
218. Reproductive Outcomes among Men Treated for Cancer
- Author
-
Mulvihill, John J., Segal, Sheldon J., editor, Olshan, Andrew F., editor, and Mattison, Donald R., editor
- Published
- 1994
- Full Text
- View/download PDF
219. The Physical Activity and Fitness in Childhood Cancer Survivors (PACCS) Study: Protocol for an International Mixed Methods Study
- Author
-
Hanne C Lie, Sigmund Anderssen, Corina Silvia Rueegg, Truls Raastad, May Grydeland, Lene Thorsen, Trine Stensrud, Elisabeth Edvardsen, Marie Hamilton Larsen, Ingrid Kristin Torsvik, Lars Peder Bovim, Miriam Götte, Päivi Maria Lähteenmäki, Susi Kriemler, Hanne Bækgaard Larsen, Martin Kaj Fridh, Kristin Ørstavik, Henrik Brun, Iren Matthews, Else Hornset, Ellen Ruud, University of Zurich, and Lie, Hanne C
- Subjects
Quality of life ,Physical activity ,Medizin ,610 Medicine & health ,Intervention ,General Medicine ,10060 Epidemiology, Biostatistics and Prevention Institute (EBPI) ,2700 General Medicine ,Physical fitness ,Barriers ,Fatigue ,Childhood cancer survivor - Abstract
Background Survivors of childhood cancer represent a growing population with a long life expectancy but high risks of treatment-induced morbidity and premature mortality. Regular physical activity (PA) may improve their long-term health; however, high-quality empirical knowledge is sparse. Objective The Physical Activity and Fitness in Childhood Cancer Survivors (PACCS) study comprises 4 work packages (WPs) aiming for the objective determination of PA and self-reported health behavior, fatigue, and quality of life (WP 1); physical fitness determination (WP 2); the evaluation of barriers to and facilitators of PA (WP 1 and 3); and the feasibility testing of an intervention to increase PA and physical fitness (WP 4). Methods The PACCS study will use a mixed methods design, combining patient-reported outcome measures and objective clinical and physiological assessments with qualitative data gathering methods. A total of 500 survivors of childhood cancer aged 9 to 18 years with ≥1 year after treatment completion will be recruited in follow-up care clinics in Norway, Denmark, Finland, Germany, and Switzerland. All participants will participate in WP 1, of which approximately 150, 40, and 30 will be recruited to WP 2, WP3, and WP 4, respectively. The reference material for WP 1 is available from existing studies, whereas WP 2 will recruit healthy controls. PA levels will be measured using ActiGraph accelerometers and self-reports. Validated questionnaires will be used to assess health behaviors, fatigue, and quality of life. Physical fitness will be measured by a cardiopulmonary exercise test, isometric muscle strength tests, and muscle power and endurance tests. Limiting factors will be identified via neurological, pulmonary, and cardiac evaluations and the assessment of body composition and muscle size. Semistructured, qualitative interviews, analyzed using systematic text condensation, will identify the perceived barriers to and facilitators of PA for survivors of childhood cancer. In WP 4, we will evaluate the feasibility of a 6-month personalized PA intervention with the involvement of local structures. Results Ethical approvals have been secured at all participating sites (Norwegian Regional Committee for Medical Research Ethics [2016/953 and 2018/739]; the Oslo University Hospital Data Protection Officer; equivalent institutions in Finland, Denmark [file H-19032270], Germany, and Switzerland [Ethics Committee of Northwestern and Central Switzerland, project ID: 2019-00410]). Data collection for WP 1 to 3 is complete. This will be completed by July 2022 for WP 4. Several publications are already in preparation, and 2 have been published. Conclusions The PACCS study will generate high-quality knowledge that will contribute to the development of an evidence-based PA intervention for young survivors of childhood cancer to improve their long-term care and health. We will identify physiological, psychological, and social barriers to PA that can be targeted in interventions with immediate benefits for young survivors of childhood cancer in need of rehabilitation. International Registered Report Identifier (IRRID) DERR1-10.2196/35838
- Published
- 2021
- Full Text
- View/download PDF
220. Serum Anti-Müllerian Hormone Levels and Risk of Premature Ovarian Insufficiency in Female Childhood Cancer Survivors: Systematic Review and Network Meta-Analysis
- Author
-
Marco Torella, Gaetano Riemma, Pasquale De Franciscis, Marco La Verde, Nicola Colacurci, Torella, M., Riemma, G., De Franciscis, P., La Verde, M., and Colacurci, N.
- Subjects
fertility ,Cancer Research ,endocrine system ,premature ovarian insufficiency ,Alkylating agent ,childhood cancer survivors ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Anti‐Müllerian hormone ,ovarian reserve ,anti-Müllerian hormone ,Oncology ,alkylating agents ,Systematic Review ,General Economics, Econometrics and Finance ,radiotherapy ,RC254-282 ,Childhood cancer survivor - Abstract
Simple Summary Over the last twenty years, innovations in the treatment of childhood cancer have increased survival rates. However, female childhood cancer survivors (CCS) are prone to late reproductive aftereffects, including premature ovarian insufficiency (POI). Nonetheless, patients might experience different side effects on fertility according to the type of diagnosed cancer and subsequent treatment. Anti-Müllerian hormone (AMH) is currently used in reproductive medicine to screen for impaired ovarian reserves. However, it does not represent the gold standard in oncofertility. In this systematic review and network meta-analysis of age-matched case–control studies, we evaluate the role of AMH for ovarian reserve screening according to the type of childhood cancer and determined which group of survivors are more prone to POI by means of direct and indirect comparisons among the CCS cohorts. Abstract Background: Female childhood cancer survivors (CCS) might have impaired ovarian reserves, especially after alkylating agents or radiotherapy. The purpose of this systematic review and network meta-analysis is to evaluate the role of serum anti-Müllerian hormone (AMH) for ovarian reserve screening and the risk of premature ovarian insufficiency (POI) according to the subtype of childhood cancer. (2) Methods: PRISMA-NMA guidelines were followed. We carried out a network meta-analysis based on a random effects model for mixed multiple treatment comparisons to rank childhood cancers effects on fertility by surface under the cumulative ranking curve (SUCRA). Studies were selected only if they had an age-matched control group. Quality assessment was performed using Newcastle–Ottawa Scale. The co-primary outcomes were mean AMH levels and the incidence of POI. (3) Results: A total of 8 studies (1303 participants) were included. Women treated for a neuroblastoma during infancy were more likely to be ranked first for impaired AMH levels (SUCRA = 65.4%), followed by mixed CCS (SUCRA = 29.6%). The greatest rates of POI were found in neuroblastoma survivors (SUCRA = 42.5%), followed by acute lymphoid leukemia (SUCRA = 26.3%) or any other neoplasia (SUCR A = 20.5%). (4) Conclusions: AMH represents a trustworthy approach for ovarian reserve screening. Direct and indirect comparisons found no differences in mean AMH levels and POI risk between subtypes of CCS and healthy controls. SUCRA analysis showed that female neuroblastoma survivors were more at risk for reduced serum AMH levels and increased risk of POI.
- Published
- 2021
221. Everyday life during the childhood cancer trajectory-childhood cancer survivors' descriptions of the role of caring support.
- Author
-
Stenmarker M, Björk M, Golsäter M, and Enskär K
- Abstract
Background: Being diagnosed with cancer in childhood often has a direct impact on the child's opportunities to participate in activities and the child's sense of belonging in different life situations. Experiences of illness in youth affect the lives of these individuals in numerous ways and they need pronounced support to regain their normal life after treatment., Purpose: To illustrate how childhood cancer survivors describe the role of the caring support provided by healthcare professionals at diagnosis and during the cancer trajectory., Methods: A mixed methods approach was applied. Swanson's Theory of Caring was used to deductively analyze the answers in a study-specific questionnaire with Likert scales (1-5). Descriptive and comparative statistics and exploratory factor analyses were performed., Results: Sixty-two former patients, diagnosed with solid tumors/lymphoma in 1983 to 2003 in Sweden, participated. The mean time passed since treatment was 15.7 years. Swanson's caring processes Being with and Doing for were the most prominent loading categorical factor indicators. Higher scores for healthcare professionals being emotionally present (Being with), doing for others what they would do for themselves (Doing for) and being willing to understand the sick child's situation (Knowing) were highlighted by survivors older than 30 years, compared to those younger than 30 years ( p = 0.041, p = 0.045, and p = 0.013, respectively). An increased vulnerability regarding their ability to cope with difficulties (Maintain belief) was found among participants who were treated during adolescence, related to schoolchildren ( p = 0.048), and among those who had been treated with extra-cranial irradiation in comparison with no extra-cranial irradiation ( p = 0.004). The role of having a partner in comparison with being single was underlined among those who felt they had acquired the tools they needed to take care of themselves (Enabling) ( p = 0.013). The total explained variance was 63%., Conclusions: A person-centered care approach during treatment for childhood cancer, reflected by a caring model, highlights the role of healthcare professionals being emotionally present, involving children, performing actions, and with an approach that has potential long-term implications. Childhood cancer patients and survivors need not only clinically competent professionals, but professionals who provide caring interactions with compassion., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© 2023 Stenmarker, Björk, Golsäter and Enskär.)
- Published
- 2023
- Full Text
- View/download PDF
222. Excellent results of screening for subsequent breast cancers in long-term survivors of childhood Hodgkin's lymphoma-Results of a population-based study.
- Author
-
Zadravec Zaletel L, Cesen Mazic M, Jazbec J, Kos G, Toplak M, and Štrbac D
- Abstract
Introduction: Subsequent breast cancer (SBC) represents a major complication in childhood cancer survivors and screening for SBC in survivors after incidental irradiation of breasts is recommended. In this article, we report the results and discuss benefits of SBC screening in female pts treated for Hodgkin's lymphoma (HL) in Slovenia in a period of 45 years., Methods: Between 1966 and 2010, 117 females were treated for HL under the age of 19 in Slovenia. One hundred five of them survived for 5 years and were included in our study. They were 3-18 (med. 15) years old at diagnosis and followed for 6-52 (med. 28) years. Eighty-three percent of them had chest RT with a median dose of 30 Gy. Ninety-seven (92%) of 105 pts were regularly followed according to the international guidelines including yearly screening mammography/breast MRI in those who received chest RT., Results: We diagnosed 10 SBCs in eight pts 14-39 (med. 24) years after diagnosis at the age of 28-52 (med. 42) years. At 40 years of follow-up, cumulative incidence of SBCs in females who got chest RT was 15.2%. Seven of eight patients (with 9 SBCs) got chest RT with 24-80 (med. 36) Gy at the age of 12 to 18 (median 17) years. Two patients in this group got bilateral SBC. One patient got invasive SBC after being treated with ChT containing high-dose of anthracyclines without chest RT at the age of 13. All eight invasive SBCs were invasive ductal cancers, HER2 receptors negative, all but one with positive hormonal receptors. Six invasive cancers were of stage T1N0, one T1N1mi, only one, diagnosed before era of screening, was of T2N1. None of 8 pts died of SBC., Conclusion: After introduction of regular breast screening in our female patients, who received chest RT in childhood, all SBCs were of early stage and no patients died of SBC. Survivors of pediatric HL should be informed about the risk of late sequelae of treatment for HL, including SBC. Regular follow-up with breast cancer screening and breast self-examination is of vital importance in those treated with chest RT., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© 2023 Zadravec Zaletel, Cesen Mazic, Jazbec, Toplak, Kos and Štrbac.)
- Published
- 2023
- Full Text
- View/download PDF
223. Late effects of therapy in survivors of childhood and adolescent osteosarcoma
- Author
-
Nicholson, H. Stacy, Mulvihill, John J., Humphrey, G. Bennett, editor, Koops, H. Schraffordt, editor, Molenaar, W. M., editor, and Postma, A., editor
- Published
- 1993
- Full Text
- View/download PDF
224. Psychological effects of amputation in osteosarcoma
- Author
-
Tebbi, Cameron K., Humphrey, G. Bennett, editor, Koops, H. Schraffordt, editor, Molenaar, W. M., editor, and Postma, A., editor
- Published
- 1993
- Full Text
- View/download PDF
225. A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System
- Author
-
Gerrand, Craig H., Rankin, Kenneth, Banaszkiewicz, Paul A., editor, and Kader, Deiary F., editor
- Published
- 2014
- Full Text
- View/download PDF
226. Longitudinal observation of serum anti-Müllerian hormone in three girls after cancer treatment.
- Author
-
Yoko Miyoshi, Kie Yasuda, Makiko Tachibana, Hisao Yoshida, Emiko Miyashita, Takako Miyamura, Yoshiko Hashii, Kae Hashimoto, Tadashi Kimura, and Keiichi Ozono
- Subjects
- *
ANTI-Mullerian hormone , *CANCER treatment , *GIRLS' health , *FEMALE infertility , *CANCER chemotherapy ,GONADAL diseases - Abstract
Gonadal dysfunction and infertility are major endocrinological late effects among childhood cancer survivors. Chemotherapy and radiation have gonadotoxic effects and diminish the ovarian reserve. The serum concentration of anti-Müllerian hormone (AMH) is a useful marker of ovarian reserve in survivors. We conducted a longitudinal study to investigate the variations of AMH in evaluating the acute and chronic effects of cancer therapy on the ovary. Three young female patients with different hematological diseases were registered, and their medical records were reviewed. Patient 1 with myelodysplastic syndrome received reduced-intensity hematopoietic stem cell transplantation (HSCT) at 10 yr of age. Breast development and menarche occurred spontaneously after HSCT; however, AMH level became undetectable and gonadotropin did not increase. Patient 2 with acute lymphoblastic leukemia had been receiving chemotherapy since 11 yr of age. AMH level became undetectable but increased after chemotherapy and was associated with regular menstruation. Patient 3 with acute myeloid leukemia received chemotherapy at 13 yr of age and myeloablative HSCT at 14 yr of age. AMH level became undetectable after HSCT, and the patient developed amenorrhea. These different patterns in the recovery phase demonstrated that the AMH level immediately after the end of cancer therapy is inappropriate for the evaluation of the ovarian reserve. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
227. Adult childhood cancer survivors' narratives of managing their health: the unexpected and the unresolved.
- Author
-
Howard, A., Goddard, Karen, Tan de Bibiana, Jason, Pritchard, Sheila, Olson, Robert, Kazanjian, Arminee, and Howard, A Fuchsia
- Subjects
TUMORS & psychology ,COMPARATIVE studies ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,RESEARCH funding ,TUMORS ,EVALUATION research - Abstract
Purpose: Currently, 80 % of children diagnosed with cancer will be cured. However, many of these survivors go on to develop long-term health problems or late effects related to their previous cancer and therapy and require varying degrees of lifelong follow-up care. The purpose of this study was to identify the different ways that adult survivors of childhood cancer manage their medical and psychological challenges.Methods: Data from in-depth interviews with 30 adult survivors of a childhood cancer (9 to 38 years after diagnosis, currently 22 to 43 years of age, 60 % women) were analyzed using qualitative, thematic narrative analysis methods.Results: The survivors had not expected the medical, psychological, and social challenges that arose over time and that often remained unresolved. Five narrative themes revealed distinct ways that survivors managed their health challenges: (1) trying to forget cancer, (2) trusting the system to manage my follow-up care, (3) being proactive about my health, (4) stumbling from one problem to the next, and (5) struggling to find my way.Conclusions: Variation exists in the ways in which childhood cancer survivors frame their health, their perceived significance of health challenges, strategies used to manage health, interactions with healthcare professionals and the health system, and parental involvement.Implications For Cancer Survivors: This research provides novel insights that can be used to inform the development of patient-centered health services that promote the assessment and tailoring of care to the diverse ways survivors enact their agency, as well as their psychoeducational coping styles, therapeutic relationship needs, and information needs. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
228. Infertility Education: Experiences and Preferences of Childhood Cancer Survivors.
- Author
-
Cherven, Brooke O., Mertens, Ann, Wasilewski-Masker, Karen, Williamson, Rebecca, and Meacham, Lillian R.
- Abstract
The majority of children diagnosed with cancer will become long-term survivors; however, many will suffer late effects of treatment, including infertility. Educating patients about potential risk for infertility is important, yet little is known regarding when patients would like to hear this information. The purpose of this study was to assess young adult survivors' previous experience in receiving education about their risk for infertility and determine their preferences for infertility education at various time points during and after treatment. Only 36% of survivors report receiving education about risk for infertility at diagnosis, 39% at end of therapy, and 72% in long-term follow-up/survivor clinic visits. Survivors consistently identified their oncologist as a preferred educator at each time point. Although almost all participants identified wanting education at diagnosis, this time point alone may not be sufficient. End of therapy and survivorship may be times this message should be repeated and adapted for the survivor's needs and developmental stage: conversations about the impact of cancer treatment on future fertility should be ongoing. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
229. Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia.
- Author
-
Christiansen, Jon R., Massey, Richard, Dalen, Håvard, Kanellopoulos, Adriani, Hamre, Hanne, Ruud, Ellen, Kiserud, Cecilie E., Fosså, Sophie D., and Aakhus, Svend
- Abstract
Aims Little is known about right ventricular (RV) function in survivors of childhood cancer, although both anthracyclines and radiotherapy represent potentially cardiotoxic treatment. We hypothesized that adult survivors of childhood malignant lymphoma or acute lymphoblastic leukaemia would have impaired RV function. Methods and results We examined RV dimensions and function by echocardiography in 246 survivors, mean 21.7 years after diagnosis, and in 211 matched controls. Of the survivors, 84% had been exposed to anthracyclines, mediastinal radiotherapy, or both. Compared with controls, all mean measures of RV function were lower in the survivor group: fractional area change (44.5 vs. 48.6%, P < 0.001), tricuspid annular plane systolic excursion (2.24 vs. 2.49 cm, P < 0.001), peak systolic tricus-pid annular velocity (12.1 vs. 13.0 cm/s, P < 0.001), and free wall strain (226.5 vs. 228.4%, P < 0.001). In contrast, there were little differences in RV diastolic dimensions. Lower measures of RV function were found in all survivor subgroups having received cardiotoxic treatment, but not in the 16% of survivors unexposed to anthracyclines or mediastinal radiotherapy. Signs of RV systolic dysfunction were found in 30% of the survivors, and more than 3 times more often in survivors with left ventricular dysfunction. Conclusion Long-term survivors of childhood lymphoma or acute lymphoblastic leukaemia frequently have impaired RV function compared with controls. As this is associated with increased risk of heart failure and death in many other conditions, we recommend increased attention to RV function in childhood survivors. Whether RV dysfunction impairs prognosis in this patient group should be examined in longitudinal studies. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
230. The lived experiences of aboriginal adolescent survivors of childhood cancer during the recovering process in Taiwan: A descriptive qualitative research.
- Author
-
Cheng, Ya-Chun, Huang, Chu-Yu, Wu, Wei-Wen, Chang, Shu-Chuan, Lee-Hsieh, Jane, Liang, Shu-Yuan, and Cheng, Su-Fen
- Abstract
Purpose The purpose of this study was to understand the experiences of Taiwanese aboriginal adolescent survivors of childhood cancer during the process of recovery. Method A snowball sampling strategy was used to recruit participants from the pediatrics unit of a medical center in the eastern region of Taiwan. In-depth interviews were conducted with 11 aboriginal adolescent childhood cancer survivors. The data were analyzed using content analysis. Results The results revealed three major themes with subthemes within each theme. The three major themes are: roots of resilience, transformation and growth, and meaning of traditional rituals for resilience. The three subthemes within “roots of resilience” include: “feeling secure through company of family, care and financial support”, “receiving support from the important others and religion” and “learning to self-adjust”. The three subthemes revealed within “transformation and growth” are: restructuring the relationship with peers, “appreciating parents' hard work”, and “learning to seize the moment”. The two subthemes within “meaning of traditional rituals to resilience” include: “feeling blessed with the power of ancestral spirits” and “strengthening ethnic identity”. Conclusion This study provided insight into the experiences of aboriginal adolescents as they recovered from childhood cancer. The experiences made positive impacts by inspiring growth in maturity and consolidating aboriginal ethnic identity. The adolescents were empowered by support from family, friends and clansmen, and by their participation in aboriginal rituals. As healthcare professionals care for the aboriginal adolescents, it is critical to consider this culturally and ethnically specific knowledge/experience of surviving cancer to improve quality of care. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
231. Factors associated with the specific worries of childhood cancer survivors: Cross-sectional survey in Japan.
- Author
-
Ishida, Yasushi, Higaki, Takashi, Hayashi, Mitsue, Inoue, Fumiko, and Ozawa, Miwa
- Subjects
- *
TUMORS in children , *ANXIETY , *CANCER patient psychology , *CONFIDENCE intervals , *EMPLOYMENT , *QUESTIONNAIRES , *LOGISTIC regression analysis , *SOCIOECONOMIC factors , *CROSS-sectional method , *ODDS ratio , *PSYCHOLOGY - Abstract
Background Previous research has shown that adult childhood cancer survivors (CCS) have many worries. We re-analyzed the employment data in order to identify these worries and their associated factors. Methods The participants were selected from the membership directory of Heart Link mutual-aid health insurance, and recruited by the CCS Network. We conducted a cross-sectional survey (a self-rated questionnaire on employment) via post or email with a link to an Internet website. We investigated the association between CCS factors and the specific worries. The adjusted odds ratios (OR) for the associated factors with a specific worry were estimated on logistic regression analysis. Results A total of 240 questionnaires were collected by November 2012. One questionnaire was excluded because the answers were not provided by the CCS him/herself. The most common worries were health-related problems (50%) and employment issues (40%), which were followed by his/her personality and life (23%) and self-appearance (20%). Fifty (21%) out of 239 CCS answered no specific worry. The common consistent factor associated with worries was the presence of late effects. Of note was that the CCS worries were not associated with age at diagnosis or follow up, gender, educational achievement or marriage. The worry about employment issues was associated with economic status, disability qualification, and employment status. Conclusions The CCS worries were strongly affected by the presence of late effects. No significant association was noted between CCS worries and gender, age at diagnosis or follow up, or educational achievements. Economic status and disability qualification were associated with some worries. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
232. Gonadal function, fertility, and reproductive medicine in childhood and adolescent cancer patients: a national survey of Japanese pediatric endocrinologists.
- Author
-
Yoko Miyoshi, Tohru Yorifuji, Reiko Horikawa, Ikuko Takahashi, Keisuke Nagasaki, Hiroyuki Ishiguro, Ikuma Fujiwara, Junko Ito, Mari Oba, Hiroshi Kawamoto, Hiroyuki Fujisaki, Masashi Kato, Chikako Shimizu, Tomoyasu Kato, Kimikazu Matsumoto, Haruhiko Sago, Tetsuya Takimoto, Hiroshi Okada, Nao Suzuki, and Susumu Yokoya
- Subjects
- *
GONADS , *CHILDHOOD cancer , *CANCER in young adults , *INFERTILITY , *PEDIATRIC endocrinology - Abstract
An increasing number of pediatric cancer patients survive, and treatment-related infertility represents one of the most important issues for these patients. While official guidelines in Japan recommend long-term follow-up of childhood cancer survivors (CCSs), their gonadal function and fertility have not been clarified. To address this issue, we organized a working panel to compile evidence from long-term survivors who received treatments for cancer during childhood or adolescence. In collaboration with members of the CCS Committee of the Japanese Society for Pediatric Endocrinology (JSPE), we conducted a questionnaire survey regarding reproductive function in pediatric cancer patients. A cross-sectional survey was sent to 178 JSPE-certified councilors who were asked to self-evaluate the medical examinations they had performed. A total of 151 responses were obtained, revealing that 143 endocrinologists were involved in the care of CCSs. A quarter of the respondents reported having experienced issues during gonadal or reproductive examinations. Several survivors did not remember or fully understand the explanation regarding gonadal damage, and faced physical and psychological distress when discussing the risk of becoming infertile. Pediatric endocrinologists had anxieties regarding their patients' infertility and the risk of miscarriage, premature birth, and delivery problems. Only a limited number of endocrinologists had experience with managing childbirth and fertility preservation. Many councilors mentioned the necessity for inter-disciplinary communication among healthcare providers. Both endocrinologists and oncologists should set and follow a uniform clinical guideline that includes management of fertility of CCSs. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
233. Pregnancy-associated cardiomyopathy in survivors of childhood cancer.
- Author
-
Hines, Melissa, Mulrooney, Daniel, Hudson, Melissa, Ness, Kirsten, Green, Daniel, Howard, Scott, Krasin, Matthew, Metzger, Monika, Hines, Melissa R, Mulrooney, Daniel A, Hudson, Melissa M, Ness, Kirsten K, Green, Daniel M, Howard, Scott C, and Metzger, Monika L
- Subjects
HEART disease epidemiology ,TUMOR treatment ,AGE factors in disease ,ANTHRACYCLINES ,ANTINEOPLASTIC antibiotics ,CARDIOVASCULAR diseases in pregnancy ,CARDIOTOXICITY ,HEART diseases ,LONGITUDINAL method ,CARDIOMYOPATHIES ,RADIATION injuries ,RESEARCH funding ,TUMORS ,RETROSPECTIVE studies ,DISEASE complications - Abstract
Purpose: Current information regarding pregnancy-associated cardiomyopathy among women treated for childhood cancer is insufficient to appropriately guide counseling and patient management. This study aims to characterize its prevalence within a large cohort of females exposed to cardiotoxic therapy.Methods: This is a retrospective cohort study of female cancer survivors treated at St. Jude Children's Research Hospital between 1963 and 2006, at least 5 years from diagnosis, ≥13 years old at last follow-up, and with at least one successful pregnancy. Pregnancy-associated cardiomyopathy was defined as shortening fraction <28 % or ejection fraction <50 % or treatment for cardiomyopathy during or up to 5 months after completion of pregnancy.Results: Among the 847 female cancer survivors with 1554 completed pregnancies, only 3 (0.3 %) developed pregnancy-associated cardiomyopathy and 40 developed non-pregnancy-associated cardiomyopathy either 5 months postpartum (n = 14) or prior to pregnancy (n = 26). Among those with cardiomyopathy prior to pregnancy (n = 26), cardiac function deteriorated during pregnancy in eight patients (three patients with normalization of cardiac function prior to pregnancy, three with persistently abnormal cardiac function, and two for whom resolution of cardiomyopathy was unknown prior to pregnancy). Patients that developed cardiomyopathy received a higher median dose of anthracyclines compared to those that did not (321 versus 164 mg/m(2); p < 0.01).Conclusions: Pregnancy-associated cardiomyopathy in childhood cancer survivors is rare.Implications For Cancer Survivors: Most female childhood cancer survivors will have no cardiac complications during or after childbirth; however, those with a history of cardiotoxic therapies should be followed carefully during pregnancy, particularly those with a history of anthracycline exposures and if they had documented previous or current subclinical or symptomatic cardiomyopathy. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
234. Metabolic syndrome parameters, determinants, and biomarkers in adult survivors of childhood cancer: Protocol for the Dutch childhood cancer survivor study on metabolic syndrome (Dutch LATER METS)
- Author
-
Pluimakers, V. (Vincent), Fiocco, M. (Marta), van Atteveld, J. (Jenneke), Hobbelink, M. (Monique), Bresters, D. (Dorine), Dulmen-den Broeder, E. (Eline) van, Heiden-Van der Loo, M. (Margriet) van der, Janssens, G.O. (Geert), Kremer, L.C.M. (Leontien), Loonen, J.J. (Jacqueline), Louwerens, M. (Marlous), van der Pal, H. (Helena), Ronckers, C. (Cécile), Van Santen, H.M. (Hanneke M.), Versluys, B. (Birgitta), Vries, A.C.H. (Andrica) de, Heuvel-Eibrink, M.M. (Marry) van den, Neggers, S. (Sebastian), Pluimakers, V. (Vincent), Fiocco, M. (Marta), van Atteveld, J. (Jenneke), Hobbelink, M. (Monique), Bresters, D. (Dorine), Dulmen-den Broeder, E. (Eline) van, Heiden-Van der Loo, M. (Margriet) van der, Janssens, G.O. (Geert), Kremer, L.C.M. (Leontien), Loonen, J.J. (Jacqueline), Louwerens, M. (Marlous), van der Pal, H. (Helena), Ronckers, C. (Cécile), Van Santen, H.M. (Hanneke M.), Versluys, B. (Birgitta), Vries, A.C.H. (Andrica) de, Heuvel-Eibrink, M.M. (Marry) van den, and Neggers, S. (Sebastian)
- Abstract
Background: Potential late effects of treatment for childhood cancer include adiposity, insulin resistance, dyslipidemia, and hypertension. These risk factors cluster together as metabolic syndrome and increase the risk for development of diabetes mellitus and cardio- and cerebrovascular disease. Knowledge on risk factors, timely diagnosis, and preventive strategies is of importance to prevent cardio- and cerebrovascular complications and improve quality of life. Currently, no national cohort studies on the prevalence and determinants of metabolic syndrome in childhood cancer survivors, including biomarkers and genetic predisposition, are available. Objective: The objectives of the Dutch LATER METS study are to assess 1) the prevalence and risk factors of metabolic syndrome and its separate components, and 2) the potential diagnostic and predictive value of additional biomarkers for surveillance of metabolic syndrome in the national cohort of adult long-term survivors of childhood cancer. Methods
- Published
- 2021
- Full Text
- View/download PDF
235. Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations
- Author
-
Cattoni, A, Parissone, F, Porcari, I, Molinari, S, Masera, N, Franchi, M, Cesaro, S, Gaudino, R, Passoni, P, Balduzzi, A, Cattoni, A., Parissone, F., Porcari, I., Molinari, S., Masera, N., Franchi, M., Cesaro, S., Gaudino, R., Passoni, P., Balduzzi, A., Cattoni, A, Parissone, F, Porcari, I, Molinari, S, Masera, N, Franchi, M, Cesaro, S, Gaudino, R, Passoni, P, Balduzzi, A, Cattoni, A., Parissone, F., Porcari, I., Molinari, S., Masera, N., Franchi, M., Cesaro, S., Gaudino, R., Passoni, P., and Balduzzi, A.
- Abstract
In women with premature ovarian insufficiency (POI), hormonal therapy (HT) is indicated to decrease the risk of morbidity and to treat symptoms related to prolonged hypoestrogenism. While general recommendations for the management of HT in adults with POI have been published, no systematic suggestions focused on girls, adolescents and young women with POI following gonadotoxic treatments (chemotherapy, radiotherapy, stem cell transplantation) administered for pediatric cancer are available. In order to highlight the challenging issues specifically involving this cohort of patients and to provide clinicians with the proposal of practical therapeutic protocol, we revised the available literature in the light of the shared experience of a multidisciplinary team of pediatric oncologists, gynecologists and endocrinologists. We hereby present the proposals of a practical scheme to induce puberty in prepubertal girls and a decisional algorithm that should guide the clinician in approaching HT in post-pubertal adolescents and young women with iatrogenic POI.
- Published
- 2021
236. 'Det är någonting som bara sitter kvar i kroppen' - en narrativ intervjustudie med barncanceröverlevare och deras partner
- Author
-
Andersson, Isabelle and Andersson, Isabelle
- Abstract
This is a narrative study about being in a relationship with a child cancer survivor. Previous research in the field of partnership and cancer has focused on experiences of being a partner to a person who is currently in cancer treatment. There is a lack of knowledge regarding partnership to a person who has gone through a cancer treatment prior to being in the relationship. More children who are diagnosed with cancer survives today, which means that the group of adult child cancer survivors will only increase. With this growing group of adults finding their partner and getting into relationships it is important to look at how a relationship is affected by a child cancer treatment and experience. The empirical material consists of a total of 12 individual phone interviews with six couples where one of the two had been going through a cancer treatment as a child. The six couples who participated had been in a relationship for a various amount of time, ranging from a couple of months to 15 years. The narratives found in the interviews were divided into different types of narratives, problematizing and optimizing narratives. Narratives about complications from childhood cancer and conversations about the cancer experiences were two themes where the participants were divided into either problematizing or optimizing narratives. A third theme found in the interview were shared narratives, in this study meaning stories told by survivor and partner very similarly even though the interviews were conducted separately.
- Published
- 2021
237. Candlelighters: Parents and Caregivers, Friends and Allies, Working Together for Life
- Author
-
Monaco, Grace P., Kobayashi, Noboru, editor, Akera, Tai, editor, and Mizutani, Shuki, editor
- Published
- 1991
- Full Text
- View/download PDF
238. Impact of COVID‐19 pandemic on a large cohort of adult survivors of childhood cancer
- Author
-
Aaron McDonald, Kevin R. Krull, Eric J. Chow, Christopher Vukadinovich, Leslie L. Robison, Wendy M. Leisenring, Gregory T. Armstrong, James Ford, and Pamela Goodman
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,childhood cancer survivor ,health concerns ,Coronavirus disease 2019 (COVID-19) ,Childhood cancer ,Cancer Survivors ,COVID‐19 ,Neoplasms ,Health care ,Pandemic ,medicine ,Humans ,Social isolation ,Child ,Retrospective Studies ,psychosocial impact ,Survivorship: Brief Reports ,business.industry ,Siblings ,COVID-19 ,Retrospective cohort study ,Survivorship: Brief Report ,Hematology ,Middle Aged ,Oncology ,Social Isolation ,Unemployment ,Relative risk ,Pediatrics, Perinatology and Child Health ,Female ,medicine.symptom ,business ,Psychosocial - Abstract
Childhood cancersurvivors may be differentially impacted by coronavirus disease 2019 (COVID‐19). From April to June of 2020, we examined psychosocial/health concerns in 4148 adult survivors and 571 siblings. Although more survivors reported concerns about getting sick (p = .002) and needing hospitalization (p = .003) in general, survivors and siblings were comparably concerned about being infected with and the consequences of COVID‐19. Cranial radiation was associated with social isolation (relative risk [RR] = 1.3, CI = 1.1–1.7), and central nervous system (CNS) tumors were associated with unemployment due to COVID‐19 (RR = 1.7, CI = 1.2–2.2). Some survivors appear more vulnerable and may require more support to meet health care and vocational needs during COVID‐19, though siblings also perceive substantial risk.
- Published
- 2021
239. Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice
- Author
-
Cesar Luiz Boguszewski, Gudmundur Johannsson, Kevin C J Yuen, Adriane Cardoso-Demartini, Wassim Chemaitilly, Margaret C. S. Boguszewski, and Claire E Higham
- Subjects
Oncology ,Adult ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Population ,030209 endocrinology & metabolism ,Article ,Growth hormone deficiency ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Pituitary adenoma ,Internal medicine ,medicine ,Humans ,Pituitary Neoplasms ,education ,Child ,Dwarfism, Pituitary ,Childhood cancer survivor ,Cancer survivor ,education.field_of_study ,business.industry ,Brain Neoplasms ,Human Growth Hormone ,Cancer ,medicine.disease ,Craniopharyngioma ,Radiation therapy ,030220 oncology & carcinogenesis ,Growth Hormone ,business ,Growth hormone safety ,Medical literature - Abstract
Individuals surviving cancer and brain tumors may experience growth hormone (GH) deficiency as a result of tumor growth, surgical resection and/or radiotherapy involving the hypothalamic-pituitary region. Given the pro-mitogenic and anti-apoptotic properties of GH and insulin-like growth factor-I, the safety of GH replacement in this population has raised hypothetical safety concerns that have been debated for decades. Data from multicenter studies with extended follow-up have generally not found significant associations between GH replacement and cancer recurrence or mortality from cancer among childhood cancer survivors. Potential associations with secondary neoplasms, especially solid tumors, have been reported, although this risk appears to decline with longer follow-up. Data from survivors of pediatric or adult cancers who are treated with GH during adulthood are scarce, and the risk versus benefit profile of GH replacement of this population remains unclear. Studies pertaining to the safety of GH replacement in individuals treated for nonmalignant brain tumors, including craniopharyngioma and non-functioning pituitary adenoma, have generally been reassuring with regards to the risk of tumor recurrence. The present review offers a summary of the most current medical literature regarding GH treatment of patients who have survived cancer and brain tumors, with the emphasis on areas where active research is required and where consensus on clinical practice is lacking.
- Published
- 2021
240. Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors
- Author
-
G Holzer, David L. Kendler, A Tamburini, C B Confavreux, Jean-Jacques Body, Gemma Marcucci, M. L. Brandi, René Rizzoli, G Beltrami, D. D. Pierroz, Nicola Napoli, and Peyman Hadji
- Subjects
0301 basic medicine ,Peak bone mass ,Pediatrics ,medicine.medical_specialty ,medicine.medical_treatment ,Osteoporosis ,Avascular necrosis ,03 medical and health sciences ,0302 clinical medicine ,Cancer Survivors ,Bone Density ,Neoplasms ,medicine ,Chemotherapy ,Humans ,Child ,Adverse effect ,Childhood cancer survivor ,ddc:616 ,Bone mineral ,Radiotherapy ,business.industry ,Osteonecrosis ,Disease Management ,Cancer ,Hematology ,medicine.disease ,Pediatric cancer ,Radiation therapy ,chemotherapy ,childhood cancer ,childhood cancer survivor ,osteonecrosis ,osteoporosis ,radiotherapy ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Bone Remodeling ,Childhood cancer ,business - Abstract
In the past decades, new cancer treatment approaches for children and adolescents have led to a decrease in recurrence rates and an increase in long-term survival. Recent studies have focused on the evaluation of the late effects on bone of pediatric cancer-related treatments, such as chemotherapy, radiation and surgery. Treatment of childhood cancer can impair the attainment of peak bone mass, predisposing to premature onset of low bone mineral density, or causing other bone side-effects, such as bone quality impairment or avascular necrosis of bone. Lower bone mineral density and microarchitectural deterioration can persist during adulthood, thereby increasing fracture risk. Overall, long-term follow-up of childhood cancer survivors is essential to define specific groups at higher risk of long-term bone complications, identify unrecognized long-term adverse effects, and improve patient care. Children and adolescents with a cancer history should be carefully monitored, and patients should be informed of possible late complications of their previous medical treatment. The International Osteoporosis Foundation convened a working group to review the bone complications of pediatric cancer survivors, outlining recommendations for the management of bone health, in order to prevent and treat these complications.
- Published
- 2019
- Full Text
- View/download PDF
241. Satisfaction with an exercise physiology consultation after treatment for childhood cancer: An opportunity for healthy lifestyle education
- Author
-
Richard J. Cohn, David Mizrahi, David Simar, Claire E. Wakefield, Lauren Ha, and Joanna E. Fardell
- Subjects
Cancer survivor ,medicine.medical_specialty ,childhood cancer survivor ,cardiorespiratory fitness ,exercise ,business.industry ,Incidence (epidemiology) ,Childhood cancer ,Physical activity ,physical activity ,Cardiorespiratory fitness ,humanities ,RC666-701 ,Physical therapy ,health education ,Medicine ,Diseases of the circulatory (Cardiovascular) system ,Health education ,Exercise physiology ,business ,human activities ,After treatment ,exercise physiology - Abstract
Purpose: Many childhood cancer survivors are not engaging in sufficient physical activity despite high chronic disease incidence. We assessed satisfaction and acceptability of attending an exercise physiology consultation. Methods: An 8–18-year-old cancer survivor >1-year posttherapy were assessed by an exercise physiologist (T0). We assessed parents' and survivors' satisfaction and acceptability with the consultation and information received 1-month later (T1). Parents and survivors were asked whether they would see an exercise physiologist again and whether other survivors should be assessed. Results: We recruited 102 participants, with 70 unique families retained. Parents were more satisfied with information received about exercise from T0to T1 (43.4 ± 33.2 vs. 81.5 ± 17.6/100,P < 0.001). Parents reported high satisfaction from the consultation (94.7 ± 10.2/100). Most parents (96.6%) and survivors (95.9%) recommended other survivors see an exercise physiologist. Some parents (37.0%) wanted their child to be more active, while 47.8% of survivors wanted to be more active. Conclusions: There was support for an exercise physiology consultation from parents and survivors. Guidance from an exercise physiologist may be important to alter lifestyle behaviors, which can be potentially beneficial to cardiovascular and psychological well-being.
- Published
- 2019
242. Immunosenescence in Childhood Cancer Survivors and in Elderly: A Comparison and Implication for Risk Stratification
- Author
-
Petra Lázničková, Kamila Bendíčková, Tomáš Kepák, and Jan Frič
- Subjects
0301 basic medicine ,Oncology ,childhood cancer survivor ,medicine.medical_specialty ,Population ,Childhood cancer ,Inflammation ,Malignancy ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Internal medicine ,low-grade inflammation ,medicine ,accelerated aging ,late effects ,education ,immunosenescence ,education.field_of_study ,business.industry ,fungi ,RC952-954.6 ,General Medicine ,Immunosenescence ,patient stratification ,medicine.disease ,030104 developmental biology ,Increased risk ,Geriatrics ,030220 oncology & carcinogenesis ,Risk stratification ,medicine.symptom ,business - Abstract
The population of childhood cancer survivors (CCS) has grown rapidly in recent decades. Although cured of their original malignancy, these individuals are at increased risk of serious late effects, including age-associated complications. An impaired immune system has been linked to the emergence of these conditions in the elderly and CCS, likely due to senescent immune cell phenotypes accompanied by low-grade inflammation, which in the elderly is known as “inflammaging.” Whether these observations in the elderly and CCS are underpinned by similar mechanisms is unclear. If so, existing knowledge on immunosenescent phenotypes and inflammaging might potentially serve to benefit CCS. We summarize recent findings on the immune changes in CCS and the elderly, and highlight the similarities and identify areas for future research. Improving our understanding of the underlying mechanisms and immunosenescent markers of accelerated immune aging might help us to identify individuals at increased risk of serious health complications.
- Published
- 2021
243. Use of Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer
- Author
-
Celeste L. Y. Ewig, Yi Man Cheng, Hoi Shan Li, Jasper Chak Ling Wong, Alex Hong Yu Cho, Freddie Man Hong Poon, Chi Kong Li, and Yin Ting Cheung
- Subjects
childhood cancer survivor ,Cancer Research ,Pediatrics ,medicine.medical_specialty ,chronic medication prescriptions ,Childhood cancer ,lcsh:RC254-282 ,medication utilization ,03 medical and health sciences ,0302 clinical medicine ,Acute care ,Pediatric oncology ,Medicine ,030212 general & internal medicine ,polypharmacy ,Medical prescription ,Original Research ,Polypharmacy ,business.industry ,Cancer ,Retrospective cohort study ,pediatric oncology ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Transplantation ,Oncology ,030220 oncology & carcinogenesis ,business - Abstract
BackgroundAs survivors of childhood cancer age, development of cancer treatment-related chronic health conditions often occur. This study aimed to describe the pattern of chronic prescription medication use and identify factors associated with polypharmacy among survivors of childhood cancer.MethodsThis was a retrospective study conducted at the pediatric oncology long-term follow-up clinic in Hong Kong. Eligible subjects included survivors who were (1) diagnosed with cancer before 18 years old, (2) were at least 3 years post-cancer diagnosis and had completed treatment for at least 30 days, and (3) receiving long-term follow-up care at the study site between 2015 and 2018. Dispensing records of eligible survivors were reviewed to identify medications taken daily for ≥30 days or used on an “as needed” basis for ≥6 months cumulatively within the past 12-month period. Polypharmacy was defined as the concurrent use of ≥5 chronic medications. Multivariable log-binomial modeling was conducted to identify treatment and clinical factors associated with medication use pattern and polypharmacy.ResultsThis study included 625 survivors (mean current age = 17.9 years, standard deviation [SD] = 7.2 years) who were 9.2 [5.2] years post-treatment. Approximately one-third (n = 219, 35.0%) of survivors were prescribed at least one chronic medication. Frequently prescribed medication classes include systemic antihistamines (26.5%), sex hormones (19.2%), and thyroid replacement therapy (16.0%). Overall prevalence of polypharmacy was 5.3% (n = 33). A higher rate of polypharmacy was found in survivors of CNS tumors (13.6%) than in survivors of hematological malignancies (4.3%) and other solid tumors (5.3%) (P = .0051). Higher medication burden was also observed in survivors who had undergone cranial radiation (RR = 6.31; 95% CI = 2.75–14.49) or hematopoietic stem-cell transplantation (HSCT) (RR = 3.53; 95% CI = 1.59–7.83).ConclusionAlthough polypharmacy was observed in a minority of included survivors of childhood cancer, chronic medication use was common. Special attention should be paid to survivors of CNS tumors and survivors who have undergone HSCT or cranial radiation. These individuals should be monitored closely for drug–drug interactions and adverse health outcomes that may result from multiple chronic medications, particularly during hospitalization in an acute care setting.
- Published
- 2021
- Full Text
- View/download PDF
244. Examining the Factor Structure of an Adapted Posttraumatic Growth Inventory in a Sample of Childhood Cancer Survivors: A Brief Report.
- Author
-
Stal J, Ramirez CN, Huh J, Tobin J, Kim Y, Miller KA, and Milam JE
- Subjects
- Humans, Male, Child, Adult, Survivors, Adaptation, Psychological, Posttraumatic Growth, Psychological, Cancer Survivors, Stress Disorders, Post-Traumatic epidemiology, Stress Disorders, Post-Traumatic diagnosis, Stress Disorders, Post-Traumatic etiology, Neoplasms complications
- Abstract
Posttraumatic growth (PTG) represents positive changes following a trauma, crisis, and/or psychologically distressing event. Experiencing cancer can serve as a traumatic event for patients, resulting in life changes among survivors. Various PTG measures have been used to assess post-cancer change among childhood cancer survivors (CCS), but few have been evaluated for use in this population. This study examined the factor structure of an adapted, 11-item version of the Posttraumatic Growth Inventory (PTGI) among CCS. A randomly selected subgroup of participants ( N = 332) was selected from the Los Angeles Cancer Surveillance Program (mean age of 26.5 years at time of survey, mean age at diagnosis of 12 years, primarily male [53.6%], and Hispanic [51.5%]). Participants indicated the degree to which they experienced positive, negative, or no change in their life because of their cancer experience. An exploratory factor analysis (EFA) identified two factors: Appreciation of New Possibilities and Spiritual Change. The adapted, 11-item PTGI was deemed appropriate for use among CCS. Additional research is needed to confirm the use of the two-factor model with confirmatory factor analysis in an independent sample. Future research on PTG among CCS can consider spiritual change as a potential independent factor.
- Published
- 2023
- Full Text
- View/download PDF
245. Polyneuropathy in Adolescent Childhood Cancer Survivors: The PACCS Study.
- Author
-
Andries A, Ørstavik K, Rueegg CS, Eng S, Edvardsen E, Allen SM, Torsvik IK, Raastad T, Ruud E, and Nilsen KB
- Subjects
- Humans, Child, Adolescent, Cross-Sectional Studies, Exercise, Cancer Survivors, Neoplasms, Polyneuropathies
- Abstract
Background: Childhood cancer survivors (CCS) are at risk of polyneuropathy due to chemotherapy, but studies in young survivors are scarce and diagnosis is challenging. We aimed to study the presence of polyneuropathy and the possible effect of cumulative doses of chemotherapeutic agents in a representative group of adolescent survivors., Methods: CCS aged nine to 18 years and age- and sex-matched controls were recruited from the cross-sectional Physical Activity and Fitness among Childhood Cancer Survivors (PACCS) study. CCS with various cancer diagnoses who had ended cancer treatment one year or more before study were included. Polyneuropathy was evaluated clinically and with nerve conduction studies (NCSs) in three motor and five sensory nerves. We used mixed-effects linear regression models to compare CCS and controls, and investigate possible associations between cumulative chemotherapy doses and NCS amplitudes., Results: A total of 127 CCS and 87 controls were included, with 14% CCS having probable or confirmed polyneuropathy. NCS amplitudes were lower in survivors compared with controls in all nerves. The largest mean difference was 3.47 μV (95% confidence interval [CI], 2.18 to 4.75) in the tibial plantar medial sensory and 1.91 mV (95% CI, 0.78 to 3.04) in the tibial motor nerve. The cumulative dose of platinum derivatives was associated with lower tibial motor nerve amplitude (-0.20; 95% CI, -0.35 to -0.04 mV for 100 mg/m
2 dose increase) but not in other nerves. We found no significant associations between vinca alkaloids cumulative dose and amplitudes., Conclusions: CCS without clinical signs or symptoms of polyneuropathy may have subtle nerve affection. The clinical long-term impact of this novel observation should be evaluated in larger, longitudinal studies., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
246. Perceived barriers and facilitators to physical activity in childhood cancer survivors and their parents: A large-scale interview study from the International PACCS Study.
- Author
-
Larsen EH, Mellblom AV, Larsen MH, Ruud E, Thorsen L, Petersen NN, Larsen HB, Fridh MK, and Lie HC
- Subjects
- Humans, Child, Adolescent, Exercise, Parents, Qualitative Research, Cancer Survivors, Neoplasms therapy
- Abstract
Background: Physical activity (PA) may reduce risks of late effects in childhood cancer survivors, yet many have low activity levels. Using the WHO's International Classification of Functioning, Disability, and Health for Children and Youths (ICF-CY) as a conceptual framework, we aimed to identify perceived barriers and facilitators to PA in young survivors and their parents., Design/methods: We conducted individual, semi-structured interviews with 63 survivors, aged 9-18 years, ≥1-year off treatment, and 68 parents, recruited from three pediatric oncology departments in Norway and Denmark. Interviews were analyzed inductively using thematic analysis to identify barriers and facilitators to PA, which were mapped onto the ICF-CY model components; body function/structures, activities, participation, and environmental and personal factors., Results: Two-thirds of the survivors described how treatment-related impairments of bodily functions (e.g., fatigue, physical weakness, reduced lung capacity) caused physical limitations, reducing opportunities to participate in PA, especially team sports and school physical education. This resulted in a perceived ability gap between survivors and peers, reducing motivation for PA. These PA barriers were moderated by environmental factors that facilitated or further hindered PA participation (family, peer, and school support). Similarily, personal factors also facilitated (acceptance, motivation, goal setting) or hindered (anxiety, low motivation, and lack of trust) PA participation., Conclusion: Treatment-related long-term or late effects represented significant barriers to PA as their functional consequences reduced survivors' capacities and capabilities to be active. Environmental and personal factors acting as facilitators or further barriers to PA were identified. Applying the ICF-CY framework in clinical practice could help to enable PA participation., (© 2022 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
247. Updated International Guidelines for Survivorship Care after Pediatric Cancer: Practice Implications in a German and Austrian Comprehensive Care Network.
- Author
-
Gebauer J, Baust K, Bardi E, Grabow D, Calminus G, Ronckers CM, and Langer T
- Subjects
- Child, Humans, Austria, Quality of Life, Delivery of Health Care methods, Survivorship, Neoplasms therapy
- Abstract
Background: Timely diagnosis of treatment-related chronic health conditions in childhood cancer survivors (CCS) may result in reduced long-term morbidity and mortality. Evidence-based guidelines serve as a tool to implement risk-adapted screening examinations in long-term follow-up (LTFU) of CCS., Summary: New international LTFU guidelines from the last 3 years have been reviewed and included into a practical LTFU tool in order to provide an updated summary of LTFU recommendations. The inclusion of 13 new LTFU guidelines as well as 25 pragmatic recommendations resulted in an updated LTFU plan for implantation in daily practice. Special consideration of psychosocial and mental health aspects as well as recommendations for pregnant CCS complement holistic LTFU care., Key Messages: Risk-adapted LTFU in CCS offers the possibility for early detection and treatment of late effects. As these LTFU recommendations aim at asymptomatic individuals, benefits and potential risks of regular screening examinations have to be carefully balanced. Implementation of current evidence-based guidelines in clinical practice as well as the development of new application tools such as the Survivorship Passport can contribute to an individualized LTFU approach in order to ensure long-term health and quality of life in CCS., (© 2023 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
248. Multifaceted support for quality of life in childhood cancer survivors: Questionnaire survey.
- Author
-
Hirano N, Suenobu S, and Ihara K
- Subjects
- Humans, Child, Quality of Life, Survivors psychology, Surveys and Questionnaires, Cancer Survivors, Neoplasms therapy, Neoplasms psychology
- Abstract
Background: Along with improvements in curative treatment for childhood cancer, childhood cancer survivors (CCSs) often face numerous problems such as late complications of cancer treatment, social issues at school, struggles in employment, and financial difficulties. These children have received a wide range of support from the medical, educational, and administrative sectors. However, it was unclear how this multifaceted support contributed to quality of life (QOL) of CCSs in Japan., Methods: The subjects were 46 CCSs of 16 years of age or older at the time of the survey, who had been diagnosed and treated for pediatric cancer. A self-administered questionnaire survey was conducted to investigate the in-hospital status during treatment, adjustment when returning to school, and administrative social support. The QOL of CCSs was also evaluated by the Medical Outcome Study 36-Item Short-Form Health Survey., Results: Twenty-four CCSs answered the questions. The respondents who had experienced school-life problems tended to have lower role/social QOL scores (p = 0.046), whereas the CCSs who had experienced administrative counseling tended to have lower physical QOL scores (p = 0.036). The mental QOL scores tended to be higher in respondents who were informed of the exact diagnosis of cancer during hospitalization. The role/social QOL scores tended to be lower in respondents who advanced to their preferred career path., Conclusions: It is essential for three stakeholders-health-care providers, education offices, and public administrative agencies-to collaborate to share long-term psychosocial issues or concerns related to employment or daily living that CCSs may encounter, and to establish a coordinated approach to support CCSs., (© 2023 Japan Pediatric Society.)
- Published
- 2023
- Full Text
- View/download PDF
249. Clinician perceptions of Passport for Care, a web-based clinical decision support tool for survivorship care plan delivery.
- Author
-
King JE, O'Connor MC, Shohet E, Krause SM, Scheurer ME, Horowitz ME, Poplack DG, Fordis CM, and Gramatges MM
- Subjects
- Child, Humans, Survivorship, Survivors, Internet, Decision Support Systems, Clinical, Neoplasms therapy
- Abstract
Background: The Children's Oncology Group Long-Term Follow-Up Guidelines provide exposure-based risks and recommendations for late effects screening of survivors of childhood cancer. Passport for Care (PFC) is a web-based clinical decision support tool for generating a personalized survivorship care plan (SCP) derived from the Guidelines and user-entered exposures. We assessed PFC clinician user practices and perceptions of PFC impact on clinic workflow, guidelines application, and survivor shared decision-making., Procedure: A 35-item REDCap survey was emailed to all PFC users (n = 936) in 146 current and former PFC user clinics. Anonymous responses were permitted. Results were summarized and compared with a 2012 survey., Results: Data were available from 148 respondents representing 64 out of 146 PFC user clinics (minimum clinic response rate 44%, excluding 49 anonymous responses). Generation of a personalized SCP was the most common application of PFC, followed by determination of surveillance recommendations and use as a survivor database. Twenty-five respondents (17%) felt data entry was a significant or insurmountable barrier to PFC application. Sixty-nine percent of respondents attributed PFC with a very high/high impact on guidelines adherence in their clinical practice, compared with 40% who attributed PFC with having a significant impact on adherence in 2012 (p < .001)., Conclusion: The survey results provide valuable insights on patterns of SCP delivery and Survivor Clinic workflow. User-perceived benefits to PFC included facilitating clinician ability to follow guidelines recommendations in clinical practice. Importantly, some barriers to resource utilization were also identified, suggesting a need for user-informed adaptations to further improve uptake., (© 2022 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
250. Changes in body mass index in long-term childhood cancer survivors.
- Author
-
van Santen, Hanneke M., Geskus, Ronald B., Raemaekers, Steven, van Trotsenburg, A. S. Paul, Vulsma, Thomas, van der Pal, Helena J. H., Caron, Hubert N., and Kremer, Leontien C. M.
- Subjects
- *
CHILDHOOD cancer , *BODY mass index , *FOLLOW-up studies (Medicine) , *SELF-evaluation , *DIAGNOSIS , *CANCER treatment , *TUMOR diagnosis , *TUMOR treatment , *LEANNESS , *OBESITY , *TUMORS , *LOGISTIC regression analysis , *DISEASE complications - Abstract
Background: Previous studies have reported changes in the body mass index (BMI) with time in childhood cancer survivors (CCSs) during follow-up. The limitations of these studies include that they described only a subgroup of survivors or used questionnaires with self-reported heights and weights. The goal of this study was to examine BMI in a large cohort of long-term CCSs and relate this to the BMI at diagnosis, age, sex, tumor type, treatment, and endocrine defects.Methods: All patients treated for childhood cancer at the Emma Children's Hospital/Academic Medical Center between 1966 and 1996 who had survived for at least 5 years were eligible for inclusion. For 893 CCSs with a mean follow-up of 14.9 years, the BMI at the late effects outpatient clinic was compared with the BMI for the general Dutch population.Results: For girls, an increased prevalence of obesity was found. Risk factors for developing a high BMI at follow-up were a younger age and a high BMI at diagnosis and treatment with cranial radiotherapy. A significantly increased prevalence of severe underweight was found in all adult subgroups except for females aged 26 to 45 years. An association was found between a low BMI at diagnosis and a low BMI at follow-up. No treatment-related variables could be related to changes in BMI.Conclusions: The BMI at diagnosis is one of the most important predictors for the BMI at follow-up, and this suggests an important genetic or environmental cause. Adult CCSs are at high risk for developing severe underweight at follow-up. Future studies should focus on the causes and clinical consequences of underweight. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.